M. Jha, U. Balani, Vimlesh R. Pandey, Prachi Balani, V. Patel, A. Mehta
{"title":"COVID-19重症监护病房患者CHA2DS2-VASc评分与院内死亡的关系","authors":"M. Jha, U. Balani, Vimlesh R. Pandey, Prachi Balani, V. Patel, A. Mehta","doi":"10.47108/jidhealth.vol4.iss4.173","DOIUrl":null,"url":null,"abstract":"Background: CHA2DS2-VASc score is a scientifically proven risk assessment score for patients with atrial fibrillation. It may be a good predictor of in-hospital death in COVID-19 patients. The present study aimed to evaluate the association between CHA2DS2-VASc score and in-hospital mortality in the prognosis of intensive care unit (ICU) patients with COVID-19. \nMethods: Eighty-four COVID-19 patients who were hospitalized in the ICU were retrospectively analyzed in a tertiary health care center, and the CHA2DS2-VASc score was determined. All analyses were performed using SPSS statistical software (SPSS Inc., Chicago, IL, USA, 20.0). A p-value <0.05 was considered statistically significant. \nResults: The median age of patients was 60.0 years, and most were males (75.0%). Findings of the study showed that the CHA2DS2-VASc score was considerably higher among the hospitalized patients than discharged patients (3.08 ± 1.72 vs. 1.38 ± 1.16; p<0.001), and patients who required mechanical ventilation compared to those who did not require mechanical ventilation (3.03 ± 1.68 vs. 1.15 ± 0.97; P <0.001), respectively. Patients with CHA2DS2-VASc score of ≥3 had substantially higher age [67(45-87) vs. 58(19-75); P ˂0.001], computed tomography involvement score [67.5(20-90) vs. 35(15-90); P ˂0.001] and need for mechanical ventilation [29(90.6%) vs. 22(42.3%); P ˂0.001]. A significant difference was found in oxygen saturation on admission (P =0.001) between the two groups. In-hospital death was significantly higher among patients with a CHA2DS2-VASc score of ≥3 (P <0.001). The CHA2DS2-VASc score was positively correlated with white blood cells count (r=0.257, P =0.018) and negatively correlated with the number of days spent in the hospital (r=-0.184, P=0.130) due to higher in-hospital death in ICU patients with COVID-19. \nConclusion: CHA2DS2-VASc score may be an effective tool to estimate in-hospital death in COVID-19 patients who were hospitalized in the ICU.","PeriodicalId":365684,"journal":{"name":"Journal of Ideas in Health","volume":"26 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association between CHA2DS2-VASc score and in-hospital death in ICU patients with COVID-19\",\"authors\":\"M. Jha, U. Balani, Vimlesh R. Pandey, Prachi Balani, V. Patel, A. Mehta\",\"doi\":\"10.47108/jidhealth.vol4.iss4.173\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: CHA2DS2-VASc score is a scientifically proven risk assessment score for patients with atrial fibrillation. It may be a good predictor of in-hospital death in COVID-19 patients. The present study aimed to evaluate the association between CHA2DS2-VASc score and in-hospital mortality in the prognosis of intensive care unit (ICU) patients with COVID-19. \\nMethods: Eighty-four COVID-19 patients who were hospitalized in the ICU were retrospectively analyzed in a tertiary health care center, and the CHA2DS2-VASc score was determined. All analyses were performed using SPSS statistical software (SPSS Inc., Chicago, IL, USA, 20.0). A p-value <0.05 was considered statistically significant. \\nResults: The median age of patients was 60.0 years, and most were males (75.0%). Findings of the study showed that the CHA2DS2-VASc score was considerably higher among the hospitalized patients than discharged patients (3.08 ± 1.72 vs. 1.38 ± 1.16; p<0.001), and patients who required mechanical ventilation compared to those who did not require mechanical ventilation (3.03 ± 1.68 vs. 1.15 ± 0.97; P <0.001), respectively. Patients with CHA2DS2-VASc score of ≥3 had substantially higher age [67(45-87) vs. 58(19-75); P ˂0.001], computed tomography involvement score [67.5(20-90) vs. 35(15-90); P ˂0.001] and need for mechanical ventilation [29(90.6%) vs. 22(42.3%); P ˂0.001]. A significant difference was found in oxygen saturation on admission (P =0.001) between the two groups. In-hospital death was significantly higher among patients with a CHA2DS2-VASc score of ≥3 (P <0.001). The CHA2DS2-VASc score was positively correlated with white blood cells count (r=0.257, P =0.018) and negatively correlated with the number of days spent in the hospital (r=-0.184, P=0.130) due to higher in-hospital death in ICU patients with COVID-19. \\nConclusion: CHA2DS2-VASc score may be an effective tool to estimate in-hospital death in COVID-19 patients who were hospitalized in the ICU.\",\"PeriodicalId\":365684,\"journal\":{\"name\":\"Journal of Ideas in Health\",\"volume\":\"26 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Ideas in Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47108/jidhealth.vol4.iss4.173\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ideas in Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47108/jidhealth.vol4.iss4.173","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:CHA2DS2-VASc评分是经科学证实的房颤患者风险评估评分。这可能是COVID-19患者住院死亡的一个很好的预测指标。本研究旨在评估重症监护病房(ICU)患者CHA2DS2-VASc评分与住院死亡率与预后的关系。方法:回顾性分析某三级卫生保健中心ICU收治的84例COVID-19患者,测定其CHA2DS2-VASc评分。所有分析均使用SPSS统计软件(SPSS Inc., Chicago, IL, USA, 20.0)进行。p值<0.05认为有统计学意义。结果:患者中位年龄为60.0岁,男性居多(75.0%)。研究结果显示,住院患者的CHA2DS2-VASc评分明显高于出院患者(3.08±1.72∶1.38±1.16;P <0.001),需要机械通气的患者与不需要机械通气的患者相比(3.03±1.68∶1.15±0.97;P <0.001)。CHA2DS2-VASc评分≥3的患者年龄明显更高[67(45-87)vs. 58(19-75);P小于0.001],计算机断层扫描受累评分[67.5(20-90)vs. 35(15-90);P小于0.001]和机械通气需求[29(90.6%)比22(42.3%);P˂0.001]。两组患者入院时血氧饱和度差异有统计学意义(P =0.001)。CHA2DS2-VASc评分≥3分的患者住院死亡率显著增高(P <0.001)。CHA2DS2-VASc评分与白细胞计数呈正相关(r=0.257, P= 0.018),与住院天数负相关(r=-0.184, P=0.130),原因是ICU患者住院死亡率较高。结论:CHA2DS2-VASc评分可作为评估COVID-19 ICU住院患者院内死亡的有效工具。
Association between CHA2DS2-VASc score and in-hospital death in ICU patients with COVID-19
Background: CHA2DS2-VASc score is a scientifically proven risk assessment score for patients with atrial fibrillation. It may be a good predictor of in-hospital death in COVID-19 patients. The present study aimed to evaluate the association between CHA2DS2-VASc score and in-hospital mortality in the prognosis of intensive care unit (ICU) patients with COVID-19.
Methods: Eighty-four COVID-19 patients who were hospitalized in the ICU were retrospectively analyzed in a tertiary health care center, and the CHA2DS2-VASc score was determined. All analyses were performed using SPSS statistical software (SPSS Inc., Chicago, IL, USA, 20.0). A p-value <0.05 was considered statistically significant.
Results: The median age of patients was 60.0 years, and most were males (75.0%). Findings of the study showed that the CHA2DS2-VASc score was considerably higher among the hospitalized patients than discharged patients (3.08 ± 1.72 vs. 1.38 ± 1.16; p<0.001), and patients who required mechanical ventilation compared to those who did not require mechanical ventilation (3.03 ± 1.68 vs. 1.15 ± 0.97; P <0.001), respectively. Patients with CHA2DS2-VASc score of ≥3 had substantially higher age [67(45-87) vs. 58(19-75); P ˂0.001], computed tomography involvement score [67.5(20-90) vs. 35(15-90); P ˂0.001] and need for mechanical ventilation [29(90.6%) vs. 22(42.3%); P ˂0.001]. A significant difference was found in oxygen saturation on admission (P =0.001) between the two groups. In-hospital death was significantly higher among patients with a CHA2DS2-VASc score of ≥3 (P <0.001). The CHA2DS2-VASc score was positively correlated with white blood cells count (r=0.257, P =0.018) and negatively correlated with the number of days spent in the hospital (r=-0.184, P=0.130) due to higher in-hospital death in ICU patients with COVID-19.
Conclusion: CHA2DS2-VASc score may be an effective tool to estimate in-hospital death in COVID-19 patients who were hospitalized in the ICU.